---
title: "Bright Minds Biosciences (DRUG.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DRUG.US/norm.md"
symbol: "DRUG.US"
name: "Bright Minds Biosciences"
parent: "https://longbridge.com/en/quote/DRUG.US.md"
datetime: "2026-05-21T18:21:19.383Z"
locales:
  - [en](https://longbridge.com/en/quote/DRUG.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DRUG.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DRUG.US/norm.md)
---

# Bright Minds Biosciences (DRUG.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.7830 | -0.7116 | -0.4089 | -0.5402 | -0.2934 |
| ROE | -21.03% | -35.33% | -24.41% | -38.99% | -20.78% |
| Revenue | - | - | - | - | - |
| Net income | -7.51M | -5.52M | -2.93M | -3.83M | -2.06M |
| Operating income | -10.97M | -4.92M | -4.16M | -2.21M | -2.26M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 224.24M | 66.34M | 60.64M | 38.32M | 39.44M |
| Leverage | 1.01 | 1.02 | 1.03 | 1.01 | 1.01 |
| BVPS | 22.57 | 8.37 | 7.72 | 5.34 | 5.50 |
| Turnover | - | - | - | - | - |
| Cash & STI | 222.32M | 65.01M | 59.56M | 37.51M | 38.89M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 51958.36 | 67292.29 | 80432.16 | 94137.57 | 107926.52 |
| Net debt | -222.26M | -64.93M | -59.47M | -37.40M | -38.78M |

## Cash Flow Statement (USD)

| Indicator | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -6.64M | -4.25M | -910872.94 | -2.56M | -1.69M |
| Investing CF | - | - | - | - | - |
| Financing CF | 164.01M | 9.78M | 23.93M | -12313.15 | 157428.84 |
| Free CF | -5.65M | -2.92M | -894269.01 | -1.54M | -1.43M |
| OCF coverage | -35199.10% | -22347.36% | -4856.41% | -13676.56% | -9846.86% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |